Validation of the Portuguese version of the Lithium Attitudes Questionnaire (LAQ) in bipolar patients treated with lithium: cross-over study

Adriane R Rosa1,2, Ana Cristina Andreazza1,3, Jose Sanchez-Moreno2, Fernando K Gazalle4, Aida Santin1, Airton Stein5, Helena MT Barros5, Eduard Vieta2, Flávio Kapczinski1
1Bipolar Disorders Program, Centro de Pesquisas, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
2Bipolar Disorders Program, Clinical Institute of Neuroscience, Hospital Clinic de Barcelona, Barcelona, Spain
3Department of Biochemistry, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
4Post-Graduate Psychiatry Program, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
5Departamento de Farmacologia, Fundação Faculdade Federal de Ciências Médicas de Porto Alegre, Brazil

Tóm tắt

Poor adherence to lithium is very common in bipolar patients and it is a frequent cause of recurrence during prophylactic treatment. Several reports suggest that attitudes of bipolar patients interfere with adherence to lithium. The Lithium Attitudes Questionnaire (LAQ) is a brief questionnaire developed as a means of identifying and grouping the problems patients commonly have with taking lithium regularly. The original version is validated in patients, but a validated version in Portuguese is not yet available. One-hundred six patients with bipolar disorder (DSM-IV criteria) criteria under lithium treatment for at least one month were assessed using LAQ. LAQ is a brief questionnaire administered under interview conditions, which includes 19 items rating attitudes towards prophylactic lithium treatment. We analysed the internal consistency, concurrent validity, sensitivity and specificity of the Portuguese version of LAQ. The internal consistency, evaluated by Cronbach's alpha was 0.78. The mean total LAQ score was 4.1. Concurrent validity was confirmed by a negative correlation between plasma lithium concentration and total LAQ score (r = -0,198; p = 0.048). We analysed the scale's discriminative capacity revealing a sensitivity of 69% and a specificity of 71% in the identification of negative attitudes of bipolar patients. The psychometric assessment of the Portuguese version of LAQ showed good internal consistency, sensitivity and specificity. The results were similar to the original version in relation to attitudes of bipolar patients towards lithium therapy.

Từ khóa


Tài liệu tham khảo

Angst J: The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord. 1998, 50: 143-151. 10.1016/S0165-0327(98)00142-6.

Vieta E: Mood stabilization in the treatment of bipolar disorder: focus on quetiapine. Hum Psychopharmacol. 2005

Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G: Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev. 2001, CD003013-

Frye MA, Gitlin MJ, Altshuler LL: Treating acute mania. J Fam Pract. 2003, Suppl: S10-S13.

Maj M: The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence. Bipolar Disord. 2000, 2: 93-101. 10.1034/j.1399-5618.2000.020202.x.

Schou M: Perspectives on lithium treatment of bipolar disorder: action, efficacy, effect on suicidal behavior. Bipolar Disord. 1999, 1: 5-10. 10.1034/j.1399-5618.1999.10103.x.

Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C: Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry. 2000, 61: 549-555.

Jamison KR, Akiskal HS: Medication compliance in patients with bipolar disorder. Psychiatr Clin North Am. 1983, 6: 175-192.

Jamison KR, Goodwin FK: Psychotherapeutics issues in bipolar illness, in psychiatry update. The American Psychiatry Association Annual Review, vol.2. Edited by: Grinspoon L. 1983, Washington, DC, American Psychiatric Association, 319-345.

Johnson RE, McFarland BH: Lithium use and discontinuation in a health maintenance organization. Am J Psychiatry. 1996, 153: 993-1000.

Aagaard J, Vestergaard P: Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J Affect Disord. 1990, 18: 259-266. 10.1016/0165-0327(90)90077-L.

Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A: Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet. 1970, 2: 326-330. 10.1016/S0140-6736(70)92870-9.

Colom F, Vieta E: Non-adherence in psychiatric disorders: misbehaviour or clinical feature?. Acta Psychiatr Scand. 2002, 105: 161-163. 10.1034/j.1600-0447.2002.1e003.x.

Schumann C, Lenz G, Berghofer A, Muller-Oerlinghausen B: Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Res. 1999, 89: 247-257. 10.1016/S0165-1781(99)00108-0.

Scott J, Pope M: Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry. 2002, 63: 384-390.

Dharmendra MS, Eagles JM: Factors associated with patients' knowledge of and attitudes towards treatment with lithium. J Affect Disord. 2003, 75: 29-33.

Rosa AR, Marco M, Fachel JMG, Stein A, Barros HMT: Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry. 2006,

Harvey NS: The development and descriptive use of the Lithium Attitudes Questionnaire. J Affect Disord. 1991, 22: 211-219. 10.1016/0165-0327(91)90067-3.

Bullinger M, Alonso J, Apolone G, Leplege A, Sullivan M, Wood-Dauphinee S, Gandek B, Wagner A, Aaronson N, Bech P, Fukuhara S, Kaasa S, Ware JE: Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol. 1998, 51: 913-923. 10.1016/S0895-4356(98)00082-1.

Beaton DE, Bombardier C, Guillemin F, Ferraz MB: Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000, 25: 3186-3191. 10.1097/00007632-200012150-00014.

Harvey NS, Summerton AM, Forrest ARW: New direct method for measuring red cell lithium. J Clin Pathol. 1989, 42: 435-437.

Colom F, Vieta E, Sanchez-Moreno J, Martinez-Aran A, Reinares M, Goikolea JM, Scott J: Stabilizing the stabilizer: group psychoeducation enhances the stability of serum lithium levels. Bipolar Disord. 2005, 7 Suppl 5: 32-36. 10.1111/j.1399-5618.2005.00249.x.

Kessing LV, Hansen HV, Bech P: Attitudes and beliefs among patients treated with mood stabilizers. Clin Pract Epidemol Ment Health. 2006, 2: 8-10.1186/1745-0179-2-8.

Harvey NS, Peet M: Lithium maintenance: 2. Effects of personality and attitude on health information acquisition and compliance. Br J Psychiatry. 1991, 158: 200-204.